123 related articles for article (PubMed ID: 6419239)
1. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
[TBL] [Abstract][Full Text] [Related]
2. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1985 Sep; 23(3):473-8. PubMed ID: 3931103
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent reduction in maximum electroshock convulsive threshold associated with decreased concentrations of brain monoamines.
London ED; Waller SB; Vocci FJ; Buterbaugh GG
Pharmacol Biochem Behav; 1982 Mar; 16(3):441-7. PubMed ID: 6979051
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
5. Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction.
London ED; Buterbaugh GG
J Pharmacol Exp Ther; 1978 Jul; 206(1):81-90. PubMed ID: 307060
[TBL] [Abstract][Full Text] [Related]
6. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Erinoff L; Snodgrass SR
Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
[TBL] [Abstract][Full Text] [Related]
7. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA.
Reader TA; Gauthier P
J Neural Transm; 1984; 59(3):207-27. PubMed ID: 6234377
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the local administration of 5,7-DHT and 6-OHDA into the neocortex on the learning and exploratory behavior of rats in an open field].
Ismaĭlova KhIu; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):548-55. PubMed ID: 2552698
[TBL] [Abstract][Full Text] [Related]
10. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
Pappas B; Ings R; Roberts D
Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
[TBL] [Abstract][Full Text] [Related]
11. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
12. Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol.
Frye GD; Ellis FW
Drug Alcohol Depend; 1977; 2(5-6):349-59. PubMed ID: 562250
[TBL] [Abstract][Full Text] [Related]
13. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
14. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
Nielsen JA; Moore KE
Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
[TBL] [Abstract][Full Text] [Related]
15. Effect of intranigral administration of 6-hydroxydopamine and 5,7-dihydroxytryptamine on rat brain tryptamine.
Juorio AV; Greenshaw AJ; Nguyen TV
J Neurochem; 1987 May; 48(5):1346-50. PubMed ID: 3104539
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the rat.
Lorden JF; Oltmans GA; Dawson R; Callahan M
Pharmacol Biochem Behav; 1979 Jan; 10(1):79-86. PubMed ID: 312504
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
18. Tail temperature in rats after intraventricular injections of 6-hydroxydopamine or 5,7-dihydroxytryptamine.
Ishikawa Y; Matuszek M; Nakayama T
Neurosci Lett; 1980 Nov; 20(2):177-81. PubMed ID: 7443067
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
Carruba MO; Keller HH; Da Prada M
Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
[No Abstract] [Full Text] [Related]
[Next] [New Search]